Sheng-Fung Lin

474 total citations
23 papers, 380 citations indexed

About

Sheng-Fung Lin is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Sheng-Fung Lin has authored 23 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Hematology and 6 papers in Genetics. Recurrent topics in Sheng-Fung Lin's work include Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Sheng-Fung Lin is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Sheng-Fung Lin collaborates with scholars based in Taiwan. Sheng-Fung Lin's co-authors include Pai‐Mei Lin, Ming‐Yu Yang, Cheng‐Ming Hsu, Ta‐Chih Liu, Jan‐Gowth Chang, Yu‐Ming Wang, Tyen‐Po Chen, Hui‐Hua Hsiao, Jui-Feng Hsu and Yi‐Chang Liu and has published in prestigious journals such as Blood, PLoS ONE and Clinica Chimica Acta.

In The Last Decade

Sheng-Fung Lin

23 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sheng-Fung Lin Taiwan	10	243	109	72	50	49	23	380
Usawadee Dier United States	7	216 0.9×	126 1.2×	61 0.8×	61 1.2×	96 2.0×	9	409
Xinnv Xu China	11	195 0.8×	116 1.1×	61 0.8×	45 0.9×	68 1.4×	16	325
Elena Cesaro Italy	15	425 1.7×	75 0.7×	60 0.8×	62 1.2×	46 0.9×	27	570
Yasuyuki Kaneta Japan	8	174 0.7×	39 0.4×	47 0.7×	75 1.5×	44 0.9×	10	290
Priscila Santos Scheucher Brazil	12	285 1.2×	108 1.0×	101 1.4×	62 1.2×	58 1.2×	41	488
Mingtai Chen China	12	350 1.4×	290 2.7×	50 0.7×	62 1.2×	46 0.9×	23	511
Yunxiao Xu China	13	241 1.0×	98 0.9×	132 1.8×	51 1.0×	56 1.1×	21	387
D Chatterjee United States	9	365 1.5×	109 1.0×	30 0.4×	126 2.5×	67 1.4×	17	497
Inês Mota Portugal	11	125 0.5×	48 0.4×	91 1.3×	117 2.3×	20 0.4×	21	382
Shamika Ketkar United States	11	367 1.5×	141 1.3×	187 2.6×	31 0.6×	43 0.9×	22	631

Countries citing papers authored by Sheng-Fung Lin

Since Specialization

Citations

This map shows the geographic impact of Sheng-Fung Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng-Fung Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng-Fung Lin more than expected).

Fields of papers citing papers by Sheng-Fung Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng-Fung Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng-Fung Lin. The network helps show where Sheng-Fung Lin may publish in the future.

Co-authorship network of co-authors of Sheng-Fung Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng-Fung Lin. A scholar is included among the top collaborators of Sheng-Fung Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng-Fung Lin. Sheng-Fung Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hsu, Cheng‐Ming, Pai‐Mei Lin, Hsin‐Ching Lin, et al.. (2016). Altered Expression of Imprinted Genes in Squamous Cell Carcinoma of the Head and Neck.. PubMed. 36(5). 2251–8. 23 indexed citations

Hsiao, Hui‐Hua, et al.. (2013). Trimethoprim/Sulfamethoxazole-Related Acute Psychosis in the Second Course of Treatment After a Stem Cell Transplant: Case Report and Literature Review. Experimental and Clinical Transplantation. 11(5). 467–468. 4 indexed citations

Liu, Yi‐Chang, Hui‐Hua Hsiao, Chao-Sung Chang, et al.. (2013). Outcome of allotransplants in patients with chronic-phase chronic myeloid leukemia following imatinib failure: prognosis revisited.. PubMed. 33(10). 4663–7. 2 indexed citations

Hsu, Cheng‐Ming, et al.. (2012). Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. Tumor Biology. 33(6). 1933–1942. 81 indexed citations

Yang, Ming‐Yu, Pai‐Mei Lin, Yi‐Chang Liu, et al.. (2012). Induction of Cellular Senescence by Doxorubicin Is Associated with Upregulated miR-375 and Induction of Autophagy in K562 Cells. PLoS ONE. 7(5). e37205–e37205. 63 indexed citations

Liu, Yi‐Chang, et al.. (2011). JAK2V617Fmutation is associated with special alleles in essential thrombocythemia. Leukemia & lymphoma. 52(3). 478–482. 3 indexed citations

Yang, Ming‐Yu, Jan‐Gowth Chang, Pai‐Mei Lin, et al.. (2011). Altered Regulation of Imprinted Non-Coding RNA Genes in Acute Myeloid Leukemia,. Blood. 118(21). 3456–3456. 1 indexed citations

Yang, Ming‐Yu, Wen‐Chi Yang, Pai‐Mei Lin, et al.. (2010). Induction of Senescence by Doxorubicin Is Associated with Upregulated Mir-375 and Induction of Autophagy In CML Cell Line K562. Blood. 116(21). 1843–1843. 1 indexed citations

Chen, Yuk-Kwan, Kun‐Bow Tsai, Tien‐Yu Shieh, et al.. (2009). Expression of BUBR1 in human oral potentially malignant disorders and squamous cell carcinoma. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 109(2). 257–267. 15 indexed citations

10.

Er, Tze‐Kiong, et al.. (2009). Detection of the JAK2 V617F missense mutation by high resolution melting analysis and its validation. Clinica Chimica Acta. 408(1-2). 39–44. 23 indexed citations

11.

Er, Tze‐Kiong, Shih‐Meng Tsai, Szu‐Hsien Wu, et al.. (2007). Antioxidant status and superoxide anion radical generation in acute myeloid leukemia. Clinical Biochemistry. 40(13-14). 1015–1019. 42 indexed citations

12.

Yang, Sheng‐Huei, Mei‐Chin Lu, Yung‐Ning Yang, et al.. (2006). Effects of cardiotoxin III on expression of genes and proteins related to G2/M arrest and apoptosis in K562 cells. Molecular and Cellular Biochemistry. 300(1-2). 185–190. 9 indexed citations

13.

Hsiao, Hui‐Hua, Hui‐Pin Hsiao, Hui‐Jen Tsai, et al.. (2004). Case of Chronic Lymphocytic Leukemia with Unusual Chromosome Aberrations. International Journal of Hematology. 80(4). 351–353. 4 indexed citations

14.

Liu, Ta‐Chih, Sheng-Fung Lin, Chao-Sung Chang, Tyen‐Po Chen, & Jan‐Gowth Chang. (2001). A molecular genetic analysis of the Kidd blood group polymorphism in Taiwanese, Thais, and Filipinos.. PubMed. 17(11). 552–5. 1 indexed citations

15.

Liu, Ta‐Chih, et al.. (2000). Mutation analysis of PTEN/MMAC1 in acute myeloid leukemia. American Journal of Hematology. 63(4). 170–175. 58 indexed citations

16.

Lin, Sheng-Fung, et al.. (2000). Clinical Implications Of Aberrant TSG101 Transcripts In Acute Myeloblastic Leukemia. Leukemia & lymphoma. 36(5-6). 463–466. 10 indexed citations

17.

Liu, Ta‐Chih, et al.. (2000). Molecular basis of Lewis blood type in Taiwanese.. PubMed. 16(11). 552–8. 2 indexed citations

18.

Chen, Tyen‐Po, et al.. (1995). Clonal analysis in acute myeloid leukemia by polymerase chain reaction.. PubMed. 11(4). 191–6. 1 indexed citations

19.

Lin, Sheng-Fung, et al.. (1993). Molecular Characterization of Hb H Disease by Polymerase Chain Reaction. Acta Haematologica. 90(4). 177–181. 8 indexed citations

20.

Yen, Jeng‐Hsien, et al.. (1989). Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.. PubMed. 16(10). 1320–5. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact